Clinical Trial Update: Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma [Phase 1]

View source ↗

Summary

A completed Phase I clinical trial evaluated the combination of olaparib and temozolomide in patients with Ewing sarcoma and rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Lynparza (olaparib)
• Temodar (Temozolomide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 | Status: COMPLETED